EquityZen Growth Technology Fund LLC - Series 1772
Raised
$178K
Investors
11
Min Invest
$10,003
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1772 is a Delaware LLC filed by EquityZen Advisors on 2023-08-30, raising $178K from 11 investors under Rule 506(b) and Section 3(c)(1). The offering has a $10K minimum investment and is part of EquityZen's pre-IPO platform, which operates over 1,800 related fund series providing access to private company equity.
This pre-IPO pooled investment fund uses the standard 506(b)/3(c)(1) exemption structure typical of retail-accessible private equity platforms. The $10K minimum places it in the mass-affluent accessibility tier, significantly lower than institutional-only offerings but consistent with democratized secondary market platforms.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
